We are live on ! Find out more
N

NanoDimension Portfolio holdings

AUM $24.7M
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-54.02%
1 Year Est. Return
-74.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$45.6M
AUM Growth
-$65.9M
Cap. Flow
-$884K
Cap. Flow %
-1.94%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ICVX
Icosavax, Inc. Common Stock
ICVX
+$884K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICVX
1
DELISTED
Icosavax, Inc. Common Stock
ICVX
$19M 41.59%
2,693,772
-56,222
-2% -$884K
TWST icon
2
Twist Bioscience
TWST
$5.77B
$15.2M 33.33%
307,740
SQZ
3
DELISTED
SQZ Biotechnologies Company
SQZ
$6.95M 15.25%
1,445,221
RNAC icon
4
Cartesian Therapeutics
RNAC
$235M
$4.49M 9.84%
121,597

Similar funds

NanoDimension's Q1 2022 Portfolio in Review

As of Q1 2022, NanoDimension held 4 positions worth $45.6M, down 59% from $112M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0%. NanoDimension opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • NanoDimension's biggest Q1 2022 reduction was Icosavax, Inc. Common Stock, cutting an estimated $884K.
  • NanoDimension's ten largest holdings make up 100% of its $45.6M portfolio in Q1 2022.
  • NanoDimension opened 0 new positions and closed 0 in Q1 2022.
  • NanoDimension's portfolio value fell 59% quarter-over-quarter to $45.6M.

Based on NanoDimension's 13F filing for Q1 2022, filed 11 May 2022.